Requires insurers to cover buprenorphine without a copayment or deductible.

Rhode Island Bill Summary: No-Cost Buprenorphine Coverage

This bill would require health insurance companies in Rhode Island to cover buprenorphine — a medication commonly used to treat opioid addiction — without charging patients any out-of-pocket costs. That means no copayments and no deductibles when someone needs this drug. Currently, insurance plans may require patients to pay a portion of the cost themselves, which can be a barrier for people seeking treatment.

Buprenorphine (sold under brand names like Suboxone) is one of the most widely used medications for opioid use disorder. It helps reduce cravings and withdrawal symptoms, making it easier for people to recover from opioid addiction. This bill would affect anyone in Rhode Island who has private health insurance or an accident and sickness insurance policy and needs this medication as part of their treatment.

The people most directly affected would be Rhode Islanders struggling with opioid addiction who rely on insurance to help cover their treatment costs. By removing cost-sharing requirements, the bill aims to make it easier and more affordable for patients to access and stay on this medication. Insurance companies operating in Rhode Island would be required to update their coverage policies to comply with the new rule if the bill becomes law.

The bill has been introduced in the Rhode Island Senate and referred to the Senate Health and Human Services Committee, where it will be reviewed before any further action is taken.